Found: 182
Select item for more details and to access through your institution.
Antonello Covacci (1957–2023), a visionary and beautiful mind.
- Published in:
- EMBO Journal, 2024, v. 43, n. 16, p. 3307, doi. 10.1038/s44318-024-00167-5
- By:
- Publication type:
- Article
Vaccination for healthy aging.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 745, p. 1, doi. 10.1126/scitranslmed.adm9183
- By:
- Publication type:
- Article
Development of a visual Adhesion/Invasion Inhibition Assay to assess the functionality of Shigella-specific antibodies.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1374293
- By:
- Publication type:
- Article
Deep-learning image analysis for high-throughput screening of opsono-phagocytosis-promoting monoclonal antibodies against Neisseria gonorrhoeae.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-55606-4
- By:
- Publication type:
- Article
Testing a Recombinant Form of Tetanus Toxoid as a Carrier Protein for Glycoconjugate Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1770, doi. 10.3390/vaccines11121770
- By:
- Publication type:
- Article
A next-generation GMMA-based vaccine candidate to fight shigellosis.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00725-8
- By:
- Publication type:
- Article
A next-generation GMMA-based vaccine candidate to fight shigellosis.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00725-8
- By:
- Publication type:
- Article
High-throughput bactericidal assays for monoclonal antibody screening against antimicrobial resistant Neisseria gonorrhoeae.
- Published in:
- Frontiers in Microbiology, 2023, p. 1, doi. 10.3389/fmicb.2023.1243427
- By:
- Publication type:
- Article
Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00702-1
- By:
- Publication type:
- Article
mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37422-y
- By:
- Publication type:
- Article
Save the microbes to save the planet. A call to action of the International Union of the Microbiological Societies (IUMS).
- Published in:
- One Health Outlook, 2023, v. 5, n. 1, p. 1, doi. 10.1186/s42522-023-00077-2
- By:
- Publication type:
- Article
Vaccines for a sustainable planet.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 685, p. 1, doi. 10.1126/scitranslmed.adf1093
- By:
- Publication type:
- Article
2D NMR Analysis as a Sensitive Tool for Evaluating the Higher-Order Structural Integrity of Monoclonal Antibody against COVID-19.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/pharmaceutics14101981
- By:
- Publication type:
- Article
Production of two SARS-CoV-2 neutralizing antibodies with different potencies in Nicotiana benthamiana.
- Published in:
- Frontiers in Plant Science, 2022, v. 13, p. 1, doi. 10.3389/fpls.2022.956741
- By:
- Publication type:
- Article
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03849-0
- By:
- Publication type:
- Article
Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions.
- Published in:
- Biomedicines, 2022, v. 10, n. 9, p. 2126, doi. 10.3390/biomedicines10092126
- By:
- Publication type:
- Article
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections.
- Published in:
- Biomedicines, 2022, v. 10, n. 8, p. N.PAG, doi. 10.3390/biomedicines10081861
- By:
- Publication type:
- Article
Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00497-7
- By:
- Publication type:
- Article
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31115-8
- By:
- Publication type:
- Article
Innovative vaccine approaches—a Keystone Symposia report.
- Published in:
- Annals of the New York Academy of Sciences, 2022, v. 1511, n. 1, p. 59, doi. 10.1111/nyas.14739
- By:
- Publication type:
- Article
The trillion dollar vaccine gap.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 638, p. 1, doi. 10.1126/scitranslmed.abn4342
- By:
- Publication type:
- Article
Vaccines 2020: The era of the digital vaccine is here.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 624, p. 1, doi. 10.1126/scitranslmed.abm3249
- By:
- Publication type:
- Article
A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model.
- Published in:
- BMC Infectious Diseases, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12879-021-06906-x
- By:
- Publication type:
- Article
Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00388-3
- By:
- Publication type:
- Article
Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes.
- Published in:
- PLoS Neglected Tropical Diseases, 2021, v. 15, n. 10, p. 1, doi. 10.1371/journal.pntd.0009826
- By:
- Publication type:
- Article
The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 6, p. 1, doi. 10.15252/emmm.202114035
- By:
- Publication type:
- Article
Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster Extension.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. N.PAG, doi. 10.3389/fimmu.2021.671325
- By:
- Publication type:
- Article
4CMenB Immunization Induces Serum Bactericidal Antibodies Against Non-Serogroup B Meningococcal Strains in Adolescents.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 1, p. 307, doi. 10.1007/s40121-020-00370-x
- By:
- Publication type:
- Article
Rational Design of a Glycoconjugate Vaccine against Group A Streptococcus.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8558, doi. 10.3390/ijms21228558
- By:
- Publication type:
- Article
4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 10, p. 1, doi. 10.1371/journal.ppat.1008882
- By:
- Publication type:
- Article
Vaccines against Meningococcal Diseases.
- Published in:
- Microorganisms, 2020, v. 8, n. 10, p. 1521, doi. 10.3390/microorganisms8101521
- By:
- Publication type:
- Article
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population.
- Published in:
- Seminars in Immunopathology, 2020, v. 42, n. 5, p. 619, doi. 10.1007/s00281-020-00821-0
- By:
- Publication type:
- Article
Meningococcal factor H binding protein as immune evasion factor and vaccine antigen.
- Published in:
- FEBS Letters, 2020, v. 594, n. 16, p. 2657, doi. 10.1002/1873-3468.13793
- By:
- Publication type:
- Article
Corrigendum: Vaccines Against Antimicrobial Resistance.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Development of vaccines at the time of COVID-19.
- Published in:
- MicroLife, 2020, v. 1, n. 1, p. 1, doi. 10.1093/femsml/uqaa003
- By:
- Publication type:
- Article
Vaccines Against Antimicrobial Resistance.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01048
- By:
- Publication type:
- Article
Drugs and Vaccines Will Be Necessary to Control Tuberculosis.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Editorial: Advanced Immunization Technologies for Next Generation Vaccines.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Vaccine innovations for emerging infectious diseases—a symposium report.
- Published in:
- Annals of the New York Academy of Sciences, 2020, v. 1462, n. 1, p. 14, doi. 10.1111/nyas.14235
- By:
- Publication type:
- Article
Editorial: Reverse Vaccinology.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Editorial: A Global Perspective on Vaccines: Priorities, Challenges and Online Information.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Vaccine Evolution and Its Application to Fight Modern Threats.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01722
- By:
- Publication type:
- Article
Vaccines and global health: In search of a sustainable model for vaccine development and delivery.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 497, p. 1, doi. 10.1126/scitranslmed.aaw2888
- By:
- Publication type:
- Article
Glycoconjugate vaccines: Principles and mechanisms.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 456, p. 1, doi. 10.1126/scitranslmed.aat4615
- By:
- Publication type:
- Article
Role of O-Acetylation in the Immunogenicity of Bacterial Polysaccharide Vaccines.
- Published in:
- Molecules, 2018, v. 23, n. 6, p. 1340, doi. 10.3390/molecules23061340
- By:
- Publication type:
- Article
Changing Priorities in vaccinology: Antibiotic Resistance Moving to the Top.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.01068
- By:
- Publication type:
- Article
Towards a more comprehensive approach for a total economic assessment of vaccines?
- Published in:
- Journal of Market Access & Health Policy, 2017, v. 5, n. 1, p. N.PAG, doi. 10.1080/20016689.2017.1335162
- By:
- Publication type:
- Article
2. How is the economic assessment of vaccines performed today?
- Published in:
- Journal of Market Access & Health Policy, 2017, v. 5, n. 1, p. N.PAG, doi. 10.1080/20016689.2017.1335163
- By:
- Publication type:
- Article
3. How comprehensive can we be in the economic assessment of vaccines?
- Published in:
- Journal of Market Access & Health Policy, 2017, v. 5, n. 1, p. N.PAG, doi. 10.1080/20016689.2017.1336044
- By:
- Publication type:
- Article
Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants.
- Published in:
- Scientific Reports, 2016, p. 39097, doi. 10.1038/srep39097
- By:
- Publication type:
- Article